Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...

Shingles is a painful, blistering rash that can last for weeks—often disrupting work, family time, sleep, and daily routines.

GSK plc’s strong oncology growth, highlighted by Ojjaara sales and an upgraded 2025 outlook, earns a continued 'Buy' rating.

ANTWERPEN, BE / ACCESS Newswire / October 9, 2025 /OMP, a leader in supply chain planning solutions, is spotlighting at the ...

Part of a pharmaceutical factory which opened more than 75 years ago will be demolished. GSK plc (formerly GlaxoSmithKline) ...

GSK (LSE:GSK) shares have delivered a solid run recently, gaining 9% over the past month and 14% in the past 3 months. Investors are keeping an eye on what is driving this positive momentum and how ...

U.S. Health Secretary Robert F Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after ...

Health Secretary Robert F. Kennedy Jr. and the Food and Drug Administration on Monday enlisted GSK to help fast-track ...

GSK plc (LSE/NYSE: GSK) has unveiled a major update to its Vaccine Track platform, expanding the interactive public data tool to include vaccination trends across 387 U.S.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

The acting director of the US Centers for Disease Control and Prevention called for vaccine makers to develop separate shots ...

Former GSK and Sanofi executive, led Cervarix ® development and advanced pioneering therapies for rare diseases, decade of experience as venture capitalist; Strengthens Bioxodes ...